rafael rodriguez-puertas - Publications

Affiliations: 
Univ P Vasco, Leioa, Euskadi, Spain 
Area:
Neuropharmacology

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Moreno-Rodriguez M, Perez SE, Martinez-Gardeazabal J, Manuel I, Malek-Ahmadi M, Rodriguez-Puertas R, Mufson EJ. Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 38578893 DOI: 10.3233/JAD-231485  0.776
2022 Martínez-Gardeazabal J, Moreno-Rodríguez M, de San Román EG, Abad B, Manuel I, Rodríguez-Puertas R. Mass Spectrometry for the Advancement of Lipid Analysis in Alzheimer's Research. Methods in Molecular Biology (Clifton, N.J.). 2561: 245-259. PMID 36399274 DOI: 10.1007/978-1-0716-2655-9_13  0.764
2022 Llorente-Ovejero A, Bengoetxea de Tena I, Martínez-Gardeazabal J, Moreno-Rodríguez M, Lombardero L, Manuel I, Rodríguez-Puertas R. Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion. Acs Pharmacology & Translational Science. 5: 791-802. PMID 36110372 DOI: 10.1021/acsptsci.2c00069  0.742
2022 Bengoetxea de Tena I, Moreno-Rodríguez M, Llorente-Ovejero A, Monge-Benito S, Martínez-Gardeazabal J, Onandia-Hinchado I, Manuel I, Giménez-Llort L, Rodríguez-Puertas R. Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis. The European Journal of Neuroscience. 55: 1532-1546. PMID 35266590 DOI: 10.1111/ejn.15642  0.756
2021 González de San Román E, Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, Giménez-Llort L, Manuel I, Rodríguez-Puertas R. Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease. International Journal of Molecular Sciences. 22. PMID 34830150 DOI: 10.3390/ijms222212256  0.798
2021 Llorente-Ovejero A, Martínez-Gardeazabal J, Moreno-Rodríguez M, Lombardero L, González de San Román E, Manuel I, Giralt MT, Rodríguez-Puertas R. Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease. Acs Chemical Neuroscience. PMID 34037379 DOI: 10.1021/acschemneuro.1c00169  0.748
2021 Davis N, Mota BC, Stead L, Palmer EOC, Lombardero L, Rodríguez-Puertas R, de Paola V, Barnes SJ, Sastre M. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. Journal of Neuroinflammation. 18: 73. PMID 33731156 DOI: 10.1186/s12974-021-02117-y  0.781
2020 Rosell-Valle C, Pedraza C, Manuel I, Moreno-Rodríguez M, Rodríguez-Puertas R, Castilla-Ortega E, Caramés JM, Gómez Conde AI, Zambrana-Infantes E, Ortega-Pinazo J, Serrano-Castro PJ, Chun J, De Fonseca FR, Santín LJ, Estivill-Torrús G. Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110156. PMID 33152386 DOI: 10.1016/j.pnpbp.2020.110156  0.301
2020 Papon MA, Le Feuvre Y, Barreda-Gómez G, Favereaux A, Farrugia F, Bouali-Benazzouz R, Nagy F, Rodríguez-Puertas R, Landry M. Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats. Frontiers in Cellular Neuroscience. 14: 214. PMID 32765223 DOI: 10.3389/Fncel.2020.00214  0.532
2019 Fernández RA, Garate J, Tolentino-Cortez T, Herraiz A, Lombardero L, Ducrocq F, Rodriguez-Puertas R, Trifilieff P, Astigarraga E, Barreda-Gómez G, Fernandez JA. Microarray and mass spectrometry-based Methodology for lipid profiling of tissues and cell cultures. Analytical Chemistry. PMID 31751120 DOI: 10.1021/Acs.Analchem.9B04529  0.761
2018 Manterola A, Bernal-Chico A, Cipriani R, Ruiz A, Pérez-Samartín A, Moreno-Rodríguez M, Hsu KL, Cravatt B, Brown JM, Rodríguez-Puertas R, Matute C, Mato S. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology. PMID 30171986 DOI: 10.1016/J.Neuropharm.2018.08.038  0.595
2018 Mato S, Pilar-Cuéllar F, Valdizán EM, González-Maeso J, Rodríguez-Puertas R, Meana J, Sallés J, Crespo-Facorro B, Pazos Á. Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology. PMID 30099006 DOI: 10.1016/J.Bcp.2018.08.012  0.741
2018 Llorente-Ovejero A, Manuel I, Lombardero L, Giralt MT, Ledent C, Giménez-Llort L, Rodríguez-Puertas R. Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29865071 DOI: 10.3233/JAD-180137  0.808
2017 Llorente-Ovejero A, Manuel I, Giralt MT, Rodríguez-Puertas R. Increase of cortical endocannabinoid signaling in a rat model of basal forebrain cholinergic dysfunction. Neuroscience. PMID 28827178 DOI: 10.1016/j.neuroscience.2017.08.008  0.416
2017 Gónzalez de San Román E, Manuel I, Giralt MT, Ferrer I, Rodríguez-Puertas R. Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease. Biochimica Et Biophysica Acta. PMID 28527668 DOI: 10.1016/j.bbamem.2017.05.009  0.374
2017 Martínez-Gardeazabal J, González de San Román E, Moreno-Rodríguez M, Llorente-Ovejero A, Manuel I, Rodríguez-Puertas R. Lipid mapping of the rat brain for models of disease. Biochimica Et Biophysica Acta. Biomembranes. 1859: 1548-1557. PMID 28235468 DOI: 10.1016/j.bbamem.2017.02.011  0.3
2016 Manuel I, Lombardero L, Laferla FM, Giménez-Llort L, Rodríguez-Puertas R. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease. Neuroscience. PMID 27223629 DOI: 10.1016/j.neuroscience.2016.05.012  0.808
2015 Barreda-Gómez G, Lombardero L, Giralt MT, Manuel I, Rodríguez-Puertas R. Effects of galanin subchronic treatment on memory and muscarinic receptors. Neuroscience. 293: 23-34. PMID 25732139 DOI: 10.1016/j.neuroscience.2015.02.039  0.785
2015 Manuel I, Barreda-Gómez G, González de San Román E, Veloso A, Fernández JA, Giralt MT, Rodríguez-Puertas R. Neurotransmitter receptor localization: from autoradiography to imaging mass spectrometry. Acs Chemical Neuroscience. 6: 362-73. PMID 25648777 DOI: 10.1021/cn500281t  0.626
2015 Bernal-Chico A, Canedo M, Manterola A, Victoria Sánchez-Gómez M, Pérez-Samartín A, Rodríguez-Puertas R, Matute C, Mato S. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. Glia. 63: 163-76. PMID 25130621 DOI: 10.1002/Glia.22742  0.615
2014 Barreda-Gómez G, Giralt MT, Pazos A, Rodríguez-Puertas R. Galanin activated Gi/o-proteins in human and rat central nervous systems. Neuropeptides. 48: 295-304. PMID 25043784 DOI: 10.1016/j.npep.2014.06.002  0.587
2014 Manuel I, González de San Román E, Giralt MT, Ferrer I, Rodríguez-Puertas R. Type-1 cannabinoid receptor activity during Alzheimer's disease progression. Journal of Alzheimer's Disease : Jad. 42: 761-6. PMID 24946872 DOI: 10.3233/JAD-140492  0.399
2010 Morera-Herreras T, Ruiz-Ortega JA, Taupignon A, Baufreton J, Manuel I, Rodriguez-Puertas R, Ugedo L. Regulation of subthalamic neuron activity by endocannabinoids. Synapse (New York, N.Y.). 64: 682-98. PMID 20336631 DOI: 10.1002/syn.20778  0.71
1999 Rodríguez-Puertas R, Herrera-Marschitz M, Koistinaho J, Hökfelt T. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats. Neuroscience. 89: 781-97. PMID 10199613 DOI: 10.1016/S0306-4522(98)00370-4  0.516
1998 Herrera-Marschitz M, Goiny M, You ZB, Meana JJ, Engidawork E, Chen Y, Rodriguez-Puertas R, Broberger C, Andersson K, Terenius L, Hökfelt T, Ungerstedt U. Release of endogenous excitatory amino acids in the neostriatum of the rat under physiological and pharmacologically-induced conditions. Amino Acids. 14: 197-203. PMID 9871461 DOI: 10.1007/Bf01345262  0.676
1997 Herrera-Marschitz M, Goiny M, You ZB, Meana JJ, Pettersson E, Rodriguez-Puertas R, Xu ZQ, Terenius L, Hökfelt T, Ungerstedt U. On the release of glutamate and aspartate in the basal ganglia of the rat: interactions with monoamines and neuropeptides. Neuroscience and Biobehavioral Reviews. 21: 489-95. PMID 9195607 DOI: 10.1016/S0149-7634(96)00033-4  0.445
1996 Tomiyama M, Rodriguez-Puertas R, Cortés R, Christnacher A, Sommer B, Pazos A, Palacios JM, Mengod G. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience. 75: 901-15. PMID 8951883 DOI: 10.1016/0306-4522(96)00321-1  0.616
1996 Pettersson E, Herrera-Marschitz M, Rodriguez-Puertas R, Xu ZQ, You ZB, Hughes J, Elde RP, Ungerstedt U, Hökfelt T. Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via D1-subtype of receptor. Neuroscience. 74: 51-66. PMID 8843077 DOI: 10.1016/0306-4522(96)00124-8  0.467
Show low-probability matches.